CVE-2023-6515

CVE-2023-6515 describes an Authorization Bypass Through User-Controlled Key vulnerability in Mia Technology Inc.'s MİA-MED software, specifically versions prior to 1.0.7. This flaw allows for authentication abuse, enabling an attacker to bypass intended authorization mechanisms. With a CVSS score of 8.8 (HIGH), the vulnerability is easily exploitable over the network with low attack complexity, potentially leading to high impact on confidentiality, integrity, and availability. There is currently no evidence of active exploitation, public exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion surrounding this CVE.